[{"AccountsPayableCurrent_0_Q1_USD":1535000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q1_USD":30000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":103000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.0,"MarketableSecuritiesCurrent_0_Q1_USD":78040000.0,"MarketableSecurities_0_Q1_USD":110773000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q1_USD":39285000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q1_shares":93532.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":12000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":3095450.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":740000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1237000.0,"OtherLiabilitiesCurrent_0_Q1_USD":126000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":18500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":47414000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":13.91,"OperatingCostsAndExpenses_1_Q1_USD":12379000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q1_USD":8.53,"ProceedsFromStockOptionsExercised_1_Q1_USD":112000.0,"InvestmentIncomeInterest_1_Q1_USD":493000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-11835000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1_Q1_USD":0.47,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1_Q1_shares":61617.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":260481000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_1_Q1_USD":83000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1931000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_1_Q1_USD":38000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":32733000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.08,"OperatingLeaseRightOfUseAsset_0_Q1_USD":226000.0,"OperatingLeasePayments_1_Q1_USD":59000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":230000.0,"OperatingLeaseLiability_0_Q1_USD":230000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":51000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":9000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":178000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":61000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":239000.0,"LeaseCost_1_Q1_USD":94000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q1_USD":110728000.0,"CommonStockDividendsPerShareCashPaid_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-17434000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":125285000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":110773000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":1238000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.62,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":39285000.0,"StockholdersEquity_0_Q1_USD":118323000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-142206000.0,"ProfitLoss_1_Q1_USD":-11886000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":933000.0,"NetIncomeLoss_1_Q1_USD":-11886000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11317000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-6281000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":164000.0,"LiabilitiesCurrent_0_Q1_USD":8286000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":126621000.0,"Liabilities_0_Q1_USD":8298000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-724000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":588000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3588000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.42,"CommonStockValue_0_Q1_USD":3000.0,"CommonStockSharesOutstanding_0_Q1_shares":28671222.0,"CommonStockSharesIssued_0_Q1_shares":28671222.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":47245000.0,"AssetsCurrent_0_Q1_USD":126218000.0,"Assets_0_Q1_USD":126621000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":3188982.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":45000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":28499475.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":103500.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":1220.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":7.76,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":264176.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":3550000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":6462856.0,"SecurityDeposit_0_Q1_USD":20000.0,"OtherAssetsNoncurrent_0_Q1_USD":177000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":15820000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":20.08,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.09,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":24781000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":8.53,"OtherNonoperatingIncomeExpense_1_Q1_USD":493000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":657000.0,"WeightedAverageNumberOfSharesRestrictedStock_1_Q1_shares":77223.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":112000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":103385.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0163,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.806,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":1237000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":8791000.0,"OperatingIncomeLoss_1_Q1_USD":-12379000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3095450.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q1_USD":7969000.0,"Ticker":"AKRO","CIK":"1744659","name":"AKERO THERAPEUTICS, INC.","OfficialName":"Akero Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"399847718.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200513"}]